Barely Significant
← all excerpts

Pulegone and Eugenol Oral Supplementation in Laboratory Animals: Results from Acute and Chronic Studies.

Biomedicines · 2022 · PMC9599722 · PMID 36289857

Europe PMCDOI
1
hedged sentence
0.0500
closest p · 1.0× alpha
0.0500
boldest claim

The sentences

a decreasing trendp > 0.05actually significant
Despite this, there seems to be a decreasing trend of SOD activity with an increasing dose of eugenol and pulegone (groups II, III, and IV) ( p > 0.05).

also in 47,180 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.